ACC Annual Scientific Sessions 2017 - By Prof John Greenwood
Bursary recipient, John Greenwood reports from Washington DC on the American College of Cardiology 66th Annual Scientific Sessions & Expo, 17-19 March 2017.
This was an important meeting for me in many regards, not just for education and CPD. I was part of the invited Faculty, a Speaker and also co-investigator on a major late-breaking clinical trial presentation.
In addition to networking with international clinical colleagues, I had industry meetings to explore UK participation in early-phase clinical trials, and had meetings with BCS officers to develop Education strategy for 2017-2018. I am immensely grateful to have received a travel bursary from the British Cardiovascular Society (BCS) to co-fund my attendance.
My academic commitments included:
Control/Tracking Number: 17-LB-15126-ACC.
Activity: LB Late-Breaking Clinical Trial
MR-INFORM: stress perfusion imaging to guide the management of patients with stable coronary artery disease.
Eike C. Nagel, John Greenwood, Nuno Bettencourt De Sousa, Colin Berry, Gerry McCann, Ajay Shah, Chiara Bucciarelli-Ducci, Valentina O. Puntmann, Wolf-Stefan Richter, Carsten Schwenke, Divaka Perera, Mark Westwood, Sven Plein, Michael Marber, Derek Hausenloy, Rajiv Das, Joyce Wong, Henning Steen, Joseph Selvanayagam, Oliver Bruder, Wolfgang Utz, Holger Thiele, Jeanette Schulz-Menger, Heiko Mahrholdt, MRINFORM investigators, Guy's and St. Thomas' Hospital and Trust, London, United Kingdom, King's College London, London, United Kingdom
Session Title: Great Debates in Cardiac MRI
Session Time: Sunday Mar 19 2017 2:00 PM - 3:30 PM
Room: Room 140 A-B
Presentation Title or Role: Stress MRI is the Test of Choice for Ischemia Assessment.
My role in the debate was for the motion (Pro) and I was debating against Professor Prem Soman (Pittsburgh, PA), (Associate Editor, Journal of Nuclear Cardiology; & Chair, Imaging Council, American College of Cardiology (2014-15)). Hopefully I convinced the audience that my viewpoint was correct.
In addition to my roles outlined above, I attended all of the late breaking clinical trials sessions throughout the conference and witnessed first-hand many landmark trials being presented, which will undoubtedly shape cardiology practice internationally.
Once again, I am hugely grateful to the BCS for their support of my attendance at ACC2017.